Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Balazs Halmos

Showing results (151-160 of 221) with videos related to

Pageof 23
Sort By:
The Oncologist|October 24, 2020
Do Patients Regret Having Received Systemic Treatment for Advanced Non-Small Cell Lung Cancer: A Prospective EvaluationPatricia J Hollen, Richard J Gralla, Ryan D Gentzler, et al.
Cancer|September 11, 2020
Pembrolizumab plus chemotherapy versus chemotherapy alone in patients with advanced non-small cell lung cancer without tumor PD-L1 expression: A pooled analysis of 3 randomized controlled trialsHossein Borghaei, Corey J Langer, Luis Paz-Ares, et al.
Journal of Racial and Ethnic Health Disparities|June 20, 2026
Who Gets Left Out of Precision Oncology? Real-World Driver Mutation Expression Patterns and Therapeutic Eligibility in a Diverse Single-Center Early-Stage Lung Adenocarcinoma CohortGrace Ha, Lesly Diaz Chacha, Lesley Coe, et al.
Biorxiv : the Preprint Server for Biology|March 27, 2026
ATM functions as a rheostat of metabolic stress in small-cell lung cancerDebdatta Halder, Utsav Sen, Vrinda Jethalia, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2025
Summary: Appropriate Use Criteria for <sup>18</sup>F-FDG PET/CT for Initial Staging of Malignant DiseaseHossein Jadvar, Michael B Atkins, Twyla Bartel, et al.
Cells|January 24, 2025
Transcriptomic Profiling and Tumor Microenvironment Classification Reveal Unique and Dynamic Immune Biology in HIV-Associated Kaposi SarcomaJihua Yang, Ayse Ece Cali Daylan, Aleksei Shevkoplias, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screeningPasi A Jänne, Ana M Borras, Yanan Kuang, et al.
Clinical Lung Cancer|October 10, 2006
Phase II trial of sequential chemotherapy followed by chemoradiation, surgery, and postoperative chemotherapy for the treatment of stage IIIA/IIIB non-small-cell lung cancerPrudence Lam, Stuart Berman, Robert Thurer, et al.
Clinical Lung Cancer|October 4, 2025
Pembrolizumab in Combination With Platinum-Based Chemotherapy in Patients With Recurrent EGFR and ALK Gene Altered Non-Small-Cell Lung Cancer (NSCLC)Shirish M Gadgeel, Misako Nagasaka, Karen Dziubek, et al.
Cancer Research|May 11, 2011
MET-independent lung cancer cells evading EGFR kinase inhibitors are therapeutically susceptible to BH3 mimetic agentsWeiwen Fan, Zhe Tang, Lihong Yin, et al.
Pageof 23

Showing results (151-160 of 221) with videos related to

Sort By:
Pageof 23
The Oncologist|October 24, 2020
Do Patients Regret Having Received Systemic Treatment for Advanced Non-Small Cell Lung Cancer: A Prospective EvaluationPatricia J Hollen, Richard J Gralla, Ryan D Gentzler, et al.
Cancer|September 11, 2020
Pembrolizumab plus chemotherapy versus chemotherapy alone in patients with advanced non-small cell lung cancer without tumor PD-L1 expression: A pooled analysis of 3 randomized controlled trialsHossein Borghaei, Corey J Langer, Luis Paz-Ares, et al.
Journal of Racial and Ethnic Health Disparities|June 20, 2026
Who Gets Left Out of Precision Oncology? Real-World Driver Mutation Expression Patterns and Therapeutic Eligibility in a Diverse Single-Center Early-Stage Lung Adenocarcinoma CohortGrace Ha, Lesly Diaz Chacha, Lesley Coe, et al.
Biorxiv : the Preprint Server for Biology|March 27, 2026
ATM functions as a rheostat of metabolic stress in small-cell lung cancerDebdatta Halder, Utsav Sen, Vrinda Jethalia, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2025
Summary: Appropriate Use Criteria for <sup>18</sup>F-FDG PET/CT for Initial Staging of Malignant DiseaseHossein Jadvar, Michael B Atkins, Twyla Bartel, et al.
Cells|January 24, 2025
Transcriptomic Profiling and Tumor Microenvironment Classification Reveal Unique and Dynamic Immune Biology in HIV-Associated Kaposi SarcomaJihua Yang, Ayse Ece Cali Daylan, Aleksei Shevkoplias, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screeningPasi A Jänne, Ana M Borras, Yanan Kuang, et al.
Clinical Lung Cancer|October 10, 2006
Phase II trial of sequential chemotherapy followed by chemoradiation, surgery, and postoperative chemotherapy for the treatment of stage IIIA/IIIB non-small-cell lung cancerPrudence Lam, Stuart Berman, Robert Thurer, et al.
Clinical Lung Cancer|October 4, 2025
Pembrolizumab in Combination With Platinum-Based Chemotherapy in Patients With Recurrent EGFR and ALK Gene Altered Non-Small-Cell Lung Cancer (NSCLC)Shirish M Gadgeel, Misako Nagasaka, Karen Dziubek, et al.
Cancer Research|May 11, 2011
MET-independent lung cancer cells evading EGFR kinase inhibitors are therapeutically susceptible to BH3 mimetic agentsWeiwen Fan, Zhe Tang, Lihong Yin, et al.
Pageof 23